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Introduction {#sec1}
============

Human and mouse embryonic stem cells (ESCs) are both derived from the inner cell mass (ICM) of the pre-implantation epiblast but differ in transcriptomic, epigenetic, and morphological features that correspond to consecutive stages of ontogeny. Mouse ESCs (mESCs) are marked by early developmental characteristics such as expression of the core pluripotency network, including *Oct4*, *Klf4*, or *Dppa3*; the activity of both X chromosomes in females; global DNA hypomethylation; and apolar morphology of the dome-shaped mESC colonies and, therefore, show the characteristics of naive pluripotency ([@bib4]). In contrast, primed or conventional human ESCs (hESCs) are developmentally more advanced and resemble murine post-implantation epiblast or mouse epiblast stem cells, thus they are considered to be primed pluripotent ([@bib5], [@bib56]).

Several groups have aimed to capture naive pluripotency in humans and to establish culture conditions closely recapitulating the signature of human ICM cells. These studies attempted to induce a naive state in hESCs by reprogramming primed hESCs with cytokines or small molecules ([@bib15], [@bib19], [@bib55], [@bib57], [@bib62]) or by directly culturing hESCs isolated from pre-implantation ICM cells under conditions that favor naive stemness ([@bib16]). Among these, the stimulation of NANOG and KLF2 expression in 2 inhibitors (PD0325901 and CHIR99021) + Leukemia inhibitory factor (2i+Lif) conditions (inhibition of mitogen-activated protein extracellular signal-regulated kinase \[ERK\] and glycogen synthase kinase-3 beta) and subsequent restriction of protein kinase C (PKC) activity yielded hESCs with a close resemblance to the human blastocyst ([@bib17], [@bib20], [@bib55]). These reprogrammed naive hESCs express naive pluripotency markers, including OCT4, SOX2, and KLF2 and KLF4 ([@bib4]), and their metabolic and epigenetic profiles resemble the phenotype of mESCs rather than the primed state of conventional hESCs ([@bib55]).

There is still incomplete understanding of the transcriptional features that drive naive and primed pluripotency in ESCs ([@bib61], [@bib63]). Studies exploring transcriptional identity and heterogeneity in mESCs have found significant variability associated with different states of pluripotency ([@bib22], [@bib23], [@bib24]). In a recent *in vivo* study of early mouse development ([@bib37]), transcriptional noise was suggested to contribute to cell fate decision-making. However, although certain key pluripotency genes are much less variably expressed in the naive state (e.g., NANOG), single-cell RNA sequencing (scRNA-seq) suggests that overall heterogeneity in gene expression in mESC lines is independent of the respective culture condition and pluripotency state ([@bib23]).

Our understanding of *in vivo* lineage commitment in humans is much more limited. By studying transcriptional profiles of developmental stages embryonic day 3 (E3) to E7 of human preimplantation embryos, the first lineage decisions between trophectoderm, primitive endoderm, and epiblast have been described ([@bib42], [@bib54]). Furthermore, a recent study has investigated the primed-to-naive cellular state transition process and found that genes related to hemogenic endothelium development were overrepresented in naive hESCs, resulting in higher differentiation potency into hematopoietic lineages ([@bib18]). Nonetheless, the extent and details of hESC heterogeneity have not been systematically characterized, and it is unclear whether the variability in gene expression is important for differentiation. To address these questions, we performed scRNA-seq of primed hESCs and reprogrammed naive hESCs to investigate the heterogeneity within each subpopulation and to compare their molecular phenotypes with *in vivo* transcriptome studies of embryogenesis.

Results {#sec2}
=======

We assayed the transcriptomes of single primed and naive hESCs (WiCell WA09-NK2) to investigate gene expression heterogeneity and to identify potential subpopulations within different human pluripotency states. In total, we collected 480 hESCs grown under naïve titrated 2 inhibitors (PD0325901 and CHIR99021) + Leukemia inhibitory factor + inhibitor Gö6983 (t2iL+Gö) conditions ([@bib55]) and 480 hESCs grown under primed (E8) culture conditions ([@bib8]). Single cells were separated and collected using fluorescence-activated cell sorting (FACS), and full-length cDNAs were prepared using the switch mechanism at the 5′ end of RNA templates (Smart-seq2) protocol ([@bib43]), followed by Nextera XT library preparation ([Figure 1](#fig1){ref-type="fig"}A). We removed low-quality cells and normalized for cell-specific bias prior to further analyses ([STAR Methods](#sec4){ref-type="sec"}; [Figure S1](#mmc1){ref-type="supplementary-material"}A).Figure 1Naive and Primed Human ESCs Exhibit Strong Differences in Gene Expression(A) Naive and primed human ESCs were cultured in N2B27 supplemented with t2iL+Gö or in E8 medium, dissociated into single cells, and sorted into 96-well plates loaded with RLT lysis buffer and External RNA Controls Consortium (ERCC) spike-ins. RNA-seq libraries were prepared using the SmartSeq2 protocol and submitted for sequencing.(B) PCA plot of hESC expression profiles, constructed from batch-corrected and normalized log expression values of highly variable genes detected across the entire dataset. Cells are colored by their condition, and the percentage of variance explained by the first two principal components is shown.(C) Smear plot of log~2~-fold changes in expression between the naive and primed conditions, where differential expression (DE) genes were detected using edgeR at a false discovery rate (FDR) of 5%.See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

Naive and Primed hESCs Form Distinct Phenotypic Clusters {#sec2.1}
--------------------------------------------------------

To confirm that scRNA-seq can recapitulate known differences between naive and primed conditions, we performed dimensionality reduction on all cells in the dataset using principal-component analysis (PCA) on highly variable genes ([STAR Methods](#sec4){ref-type="sec"}). We observed strong separation between naive and primed cells on the first principal component ([Figure 1](#fig1){ref-type="fig"}B), indicating that the difference between conditions is the dominant factor of variation. Differential expression analysis between naive and primed conditions identified a number of genes that were strongly upregulated under each condition ([Figure 1](#fig1){ref-type="fig"}C). This included the previously reported naive pluripotency and ground state marker genes *KLF17*, *DPPA5*, *DNMT3L*, *GATA6*, *TBX3*, *IL6ST*, *DPPA3*, and *KLF5* ([@bib3], [@bib12], [@bib17], [@bib50], [@bib58], [@bib65]). Although *KLF4* has been described as a marker for both naive and primed cells ([@bib61]), we only observed its expression in naive hESCs, consistent with other studies ([@bib63]). In primed hESCs, we observed upregulation of established marker genes of primed pluripotency, such as *CD24*, *ZIC2*, and *SFRP2*, but not *OTX2* or *TFT* ([@bib6], [@bib16], [@bib51]). Shared pluripotency markers, including *SOX2*, *OCT4*, and *NANOG*, did not significantly differ between the naive and primed population.

We also identified additional (and only recently suggested; [@bib11]) markers of naive and primed hESCs ([Table 1](#tbl1){ref-type="table"}; [Figure S1](#mmc1){ref-type="supplementary-material"}B; [Table S1](#mmc2){ref-type="supplementary-material"}). The naive markers included genes that have been implicated in germ cell function (e.g., *HORMAD1* for meiotic progression; [@bib7]); *KHDC3L* as a regulator of imprinting ([@bib40]); the alkaline phosphatases *ALPP* and *ALPPL2*, which are generally used as markers of pluripotent cells ([@bib34]); as well as putative regulatory genes such as *ZNF729*. Some of these are also expressed in the early embryo; e.g., *TRIM60* ([@bib10]) and *HORMAD1* ([@bib7]). Primed markers included a number of genes related to later developmental stages; e.g., *SOX11* for neuronal development ([@bib2]), *CYTL1* for chondrogenesis and expressed at implantation ([@bib1]), *HMX2* (an NK-like \[NKL\] homeobox gene) for organogenesis ([@bib60]), and *THY1* for hematopoietic stem cells ([@bib33]). We also found regulators of key signaling pathways, such as *DUSP6* (a negative regulator of mitogen-activated protein kinase \[MAPK\] signaling) ([@bib38]) and the receptor tyrosine phosphatase *PTPRZ1* ([@bib26]). We validated a number of these genes at the protein level using proteomics ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and in bulk RNA-seq data of the hESC lines UCLA1, WIBR3, and SHEF6 under naive and primed conditions ([Table 1](#tbl1){ref-type="table"}; [Figure S1](#mmc1){ref-type="supplementary-material"}D; [@bib41], [@bib58], [@bib17]).Table 1Markers of Naive and Primed Pluripotency in hESCsNaivelogFC (WA09-NK2)logFC[∗](#tblfn1){ref-type="table-fn"} (UCLA1)[a](#tblfn2){ref-type="table-fn"}logFC[∗](#tblfn1){ref-type="table-fn"} (WIBR3)[b](#tblfn3){ref-type="table-fn"}logFC[∗](#tblfn1){ref-type="table-fn"} (SHEF6)[c](#tblfn4){ref-type="table-fn"}PrimedlogFC[∗](#tblfn1){ref-type="table-fn"} (WA09-NK2)logFC[∗](#tblfn1){ref-type="table-fn"} (UCLA1)[a](#tblfn2){ref-type="table-fn"}logFC[∗](#tblfn1){ref-type="table-fn"} (WIBR3)[b](#tblfn3){ref-type="table-fn"}logFC[∗](#tblfn1){ref-type="table-fn"} (SHEF6)[c](#tblfn4){ref-type="table-fn"}KHDC1L14.498.8213.239.36DUSP6−13.88−6.29−9.69−7.09FAM151A14.137.5710.499.20FAT3−9.80−8.44−10.76−7.65HORMAD115.037.0910.9410.25THY1−13.60−8.78−8.47−6.26ALPPL220.177.3211.268.82STC1−11.82−8.79−12.14−7.57ZNF72914.074.2511.154.83KLHL4−12.58−7.10−13.17−5.09KHDC3L19.586.8812.789.54ZDHHC22−15.53−9.02−7.86−9.44TRIM6018.537.9012.198.33NEFM−13.20−4.64−7.33−5.26MEG817.578.238.89not DEHMX2−10.58not DEnot DEnot DEOLAH10.807.5812.877.97PLA2G3−15.29−6.31−5.74−8.07LYZ17.315.477.944.70PTPRZ1−10.55−8.33−12.72−9.63HYAL417.015.929.135.66CYTL1−14.54−7.60−9.43−9.09ALPP16.584.5510.039.29SOX11−10.20−6.33−8.60−4.97[^5][^6][^7][^8]

Identification of a Subcluster in the Naive hESCs Population {#sec2.2}
------------------------------------------------------------

We observed a small group of naive cells between the main naive and primed clusters ([Figure 1](#fig1){ref-type="fig"}B). We identified these cells by hierarchical clustering within the naive population, yielding a separate cluster of 9 cells. Despite being labeled as naive, this cluster was distinguishable from the other cells in the naive population as well as from the primed population ([Figure 2](#fig2){ref-type="fig"}A). These cells expressed some naive markers (*DPPA3* and *TFCP2L1*; [Figure 2](#fig2){ref-type="fig"}B) but also exhibited primed-like characteristics (downregulation of *KLF4* and *KLF7*) ([Figure S2](#mmc1){ref-type="supplementary-material"}A); thus we labeled them "intermediate." This subpopulation does not consist of doublets from the single-cell sorting procedure because they uniquely express genes that are absent in the primed population and other naive cells.Figure 2The Naive Subpopulation Is Transcriptionally Distinct from the Other Naive and Primed Cells(A) Heatmap of the top 50 genes with the strongest differential expression between the naive and intermediate cells (top) or between the intermediate and primed cells (bottom). The box for each cell (column) and gene (row) is colored according to the log~2~-fold change from the average expression for each gene.(B) Log~2~ expression profiles of selected marker genes across cells in the naive, intermediate, and primed populations. Each point represents a cell in the corresponding population.(C) Normalized protein expression of DPPA5 against ABCG2 in naive and primed hESCs. Protein expression was determined using immunofluorescence staining of cytospin-fixed cells.(D) Representative immunofluorescence images of naive and primed hESCs using DPPA5 and ABCG2 antibodies. The scale bar represents 20 μm.See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc3){ref-type="supplementary-material"}.

One question is whether this intermediate population arises from primed cells that were not fully transformed into the naive state or from naive cells that have acquired a more primed state. To investigate this, we specifically examined the expression of imprinted genes such as *MEG3*, *PEG3*, and *SNRPN*. Loss of imprinting has been reported under all current naive hESCs culture conditions, whereas conventional hESCs rarely show imprinting defects ([@bib17], [@bib16], [@bib41]). When lost, imprinting cannot be restored in non-germline cells, which can directly affect the expression level of the imprinted genes. We found similar expression of imprinted genes in the intermediate cluster compared with naive hESCs ([Figure S2](#mmc1){ref-type="supplementary-material"}B), indicating that the subpopulation cells originate from the naive cells rather than being reprogramming-refractory remnants of the primed population that would not yet have undergone global DNA demethylation and loss of imprinting.

A number of genes were also uniquely upregulated in the intermediate population compared with both the naive and primed population. This includes *ABCG2*, *CLDN4*, *VGLL1*, *GATA2*, *GATA3*, and *ERP27* ([Figure S2](#mmc1){ref-type="supplementary-material"}C; see [Table S2](#mmc3){ref-type="supplementary-material"} for the full list), with significant over-representation of genes involved in morphological structure formation, development, and signaling (see [Figure S2](#mmc1){ref-type="supplementary-material"}D for the Gene Ontology \[GO\] analysis). This suggests that the intermediate population is a separate state from the naive and primed conditions. Indeed, the transcription of *NANOG* was strongly downregulated in the intermediate population compared with both naive and primed cells ([Figure 2](#fig2){ref-type="fig"}B). In this respect, the subpopulation state shares some transcriptional features with the recently proposed state of formative pluripotency ([@bib52]). Immunofluorescence staining based on high expression of ABCG2 and low expression of DPPA5 supported the existence of the intermediate population within the naive condition ([Figures 2](#fig2){ref-type="fig"}C and 2D).

Subclusters with Lineage-Specific Gene Expression Profiles Are Not Present in Naive or Primed hESCs {#sec2.3}
---------------------------------------------------------------------------------------------------

To study transcriptional heterogeneity within the naive and primed conditions, we applied t-distributed stochastic neighbor embedding (t-SNE) ([@bib59]) to the cells under each condition after removing all intermediate population cells from the naive condition. We did not observe any distinct clustering within each condition; instead, the major driver of heterogeneity in each condition was the cell cycle ([Figure S3](#mmc1){ref-type="supplementary-material"}A).

To focus only on heterogeneity related to embryonic development, we constructed the t-SNE plots using only a set of 184 endoderm-, ectoderm-, and mesoderm-specific markers ([Table S3](#mmc4){ref-type="supplementary-material"}). The aim was to enrich for any weak population structure related to early fate commitment. However, we still did not observe any clusters corresponding to the different germ layers in either the naive or primed populations ([Figures 3](#fig3){ref-type="fig"}A, 3B, and [S3](#mmc1){ref-type="supplementary-material"}B). This suggests that the primed cells remain in a mostly homogeneous undifferentiated state and have yet to begin the process of committing to differentiate into the germ layers.Figure 3Naive and Primed Populations Do Not Exhibit Lineage-Associated Structure, but Correlations between Lineage Markers and Epigenetic Regulators Are Stronger under the Naive Condition(A and B) Gene expression of germ layer-specific marker genes in the (A) naive and (B) primed population, visualized using tSNE on the batch-corrected normalized log expression values. Each point in the scatterplot represents a cell, which is colored by the expression of respective mesoderm (*SNAI1*), ectoderm (*ITGA6*), or endoderm (*PAF1*) markers.(C and D) Heatmaps of the strongest correlation values between selected pluripotency and lineage markers (rows) and epigenetic markers (columns) for the naive (C) and the primed (D) population. The correlation values were bound at \[−0.5, 0.5\].See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}.

The homogeneity of both the naive and primed conditions suggests that it is possible to explore co-regulatory relationships via gene-gene correlations within each population. In particular, we focused on epigenetic modulators because of their importance in controlling cellular memory and their relevance for early embryonic development. Within each condition, we computed pairwise correlations between the expression profiles of 704 epigenetic modulators with a set of 94 developmental markers ([Table S4](#mmc5){ref-type="supplementary-material"}; [Figure S3](#mmc1){ref-type="supplementary-material"}C). We observed strong correlations in the naive population ([Figure 3](#fig3){ref-type="fig"}C) that were much weaker in the primed population ([Figure 3](#fig3){ref-type="fig"}D). This indicates that the expression of the epigenetic machinery is more distinctly linked to the naive gene expression network and particularly to regulators related to *de novo* DNA and histone methylation (e.g., *DNMT3A/B* and *EHMT1*).

A Naive-to-Primed Axis Can Identify Pluripotency Transitions in Other Species {#sec2.4}
-----------------------------------------------------------------------------

To integrate our data with previous *in vivo* studies, we defined a naive-to-primed axis based on empirically defined marker genes that were strongly differentially expressed between the two conditions ([STAR Methods](#sec4){ref-type="sec"}). Cells from other scRNA-seq datasets were mapped onto this axis based on the proportion of naive-primed markers (or homologous equivalents in non-human data) they expressed. As a proof of concept, we mapped the previously described intermediate population onto the naive-to-primed signature map ([Figure S4](#mmc1){ref-type="supplementary-material"}A). The subpopulation hESCs were located close to the naive axis but expressed a lower proportion of signature markers than the residual naive population. This is consistent with our hypothesis that the intermediate population originates from naive cells but has lost some features of naive pluripotency.

Next we mapped published scRNA-seq datasets of pre-implantation embryos from mice ([@bib37]), cynomolgus monkeys ([@bib39]), and humans ([@bib42]) onto our naive-to-primed axis. For mouse and monkey embryos, we observed a gradual loss of naive marker expression and an increase in primed marker expression ([Figures 4](#fig4){ref-type="fig"}A and 4B). This is consistent with the transition from naive to primed pluripotency and suggests that the relevant genes are conserved across species. Equal proportions of naive-primed markers were expressed at approximately E5 (mice) and E9--E13 (monkeys). In contrast, we did not observe any clear shift to primed pluripotency in humans before E7 ([Figure 4](#fig4){ref-type="fig"}C), consistent with the similarity of *in vivo* naive pluripotency with *in vitro* reprogrammed naive pluripotency under the applied culture conditions ([@bib55]).Figure 4Cells Shift from a Naive-like to a Primed-like Expression Pattern during Early Embryonic DevelopmentNaive and primed markers were identified from the DE analysis of the hESC data. New cells are mapped onto the naive-primed axis based on the proportions of naive and primed markers that they express. This was performed for cells derived from mouse embryos (A), cynomolgus monkey embryos (B), and human pre-implantation embryos (C). For each plot, the density of cells is represented by the color of the pixels. Cells on the red line have equal proportions of expressed primed and naive markers.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

We also defined a naive-to-intermediate axis using the identified unique markers of our intermediate population instead of the primed markers. We observed a shift from the naive expression pattern to that of the intermediate population after E5 in the human data ([Figure S4](#mmc1){ref-type="supplementary-material"}B). This suggests that the intermediate population may also be present *in vivo* and relevant to human embryonic development.

Discussion {#sec3}
==========

By sequencing the transcriptomes of single naive and primed hESCs, we identified discrete expression signatures of the two pluripotency states. In addition to recovering existing markers ([@bib61], [@bib63]), we defined genes that are highly specific to each population. These expression markers are well conserved across species, as we were able to show by mapping mouse, monkey, and human sequencing data onto our naive-to-primed signature axis.

Another aim of this study was to clarify the heterogeneity and developmental progression of each pluripotency state in hESCs. We found that both naive and primed states of cultured hESCs were comparably homogeneous, except for a small subpopulation of cells in the naive state with transcriptional features of primed pluripotency. This was surprising because the primed state was expected to be more differentiated and possibly showing signatures of early lineage commitments, as suggested by *in vivo* work in mice ([@bib37]). However, the comparably low levels of heterogeneity of naive and primed pluripotency *in vitro* have also been observed in mESC lines ([@bib23]) and could be a reflection of the medium favoring one particular cellular phenotype. Therefore, these artificial states may be a misleading representation of primed pluripotency, which is more heterogeneous *in vivo*.

We observed that cell cycle-related effects were the most prominent source of variability within both the naive and the primed population. It is possible that specific cell cycle states may play a major role in contributing to cell fate decisions by introducing transcriptional noise. We also found that naive hESCs showed stronger correlations of pluripotency and lineage markers to epigenetic regulators than primed hESCs. Given the major epigenetic resetting observed during early embryonic development (i.e., from fertilization to the formation of the naive ICM cells; [@bib21]), the naive transcriptional state may have a unique need to be tightly coupled to the expression of the epigenetic machinery. In contrast, primed hESCs represent a later developmental stage in which the epigenetic machinery may be less strictly controlled as the epigenome is re-established in a more heterogeneous and cell type-specific manner. Future work exploring the epigenetic dynamics in early mouse and human embryonic development by single-cell epigenomics will help to dissect these mechanisms in more detail.

We also identified a subpopulation of naive hESCs that showed both features of naive and primed states. Indeed, we assume that the naive state in hESCs is temporally limited and that cells are prone to exit it. The existence of "formative" pluripotency has recently been suggested ([@bib52]). This state may represent a cellular phase where cells acquire differentiation competency and are marked by the expression of early post-implantation factors such as *OTX2*, *SOX3*, and *POU3F1* and the transient loss of *NANOG* expression. Interestingly, the intermediate population is characterized by significantly decreased *NANOG* transcription, although we did not detect significant upregulation of *OTX2*, *SOX3*, and *POU3F1*. It remains to be seen whether this subpopulation corresponds to cells exiting naive pluripotency toward formative pluripotency and whether this represents a real *in vivo* state or arises because of culture-specific conditions.

Our study provides important insights into the transcriptomic heterogeneity of naive and primed hESCs. The identification of specific markers may contribute to studying the reprogramming dynamics during the primed-to-naive transitions and delineate key transcriptional events leading to human naive pluripotency. Finally, we catalog and compare pluripotency identity across species to characterize transitions between different pluripotency states that mark specific temporal windows of embryonic development.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Human DPPA5/ESG1 AntibodyR&D SystemsAF3125-SP; RRID: [AB_2094168](nif-antibody:AB_2094168){#interref70}Human ABCG2 AntibodyR&D SystemsMAB995-SP; RRID: [AB_2220316](nif-antibody:AB_2220316){#interref75}**Chemicals, Peptides, and Recombinant Proteins**Human LIFStem Cell Institute, CambridgeN/ACHIR99021Stem Cell Institute, CambridgeN/APD0325901Stem Cell Institute, CambridgeN/AGö6983TOCRIS2285Penicillin/StreptomycinThermo Fisher Scientific15140122MEM non-essential amino acidsThermo Fisher Scientific11140050TeSR-E8STEMCELL Technologies05990B27Thermo Fisher Scientific17504044N2Stem Cell Institute, CambridgeN/ADMEM-F12Thermo Fisher Scientific11320-033NeurobasalThermo Fisher Scientific21103049AccutaseSTEMCELL Technologies07920Triton X-100Sigma-AldrichT9284Tween20Sigma-AldrichP9416DAPIThermo Fisher Scientific62248RNase InhibitorClontech2313AERCC RNA Spike-In MixAmbion4456740dNTPsThermo Fisher Scientific10319879**Critical Commercial Assays**AMPure XP beadsBeckman CoulterA63880Nextera XT DNA Sample Preparation KitIlluminaFC-131-1096Nextera XT Index KitIlluminaFC-131-1001Superscript II reverse transcriptaseInvitrogen18064-014**Deposited Data**Raw sequence data and count tablesThis studyE-MTAB-6819**Experimental Models: Cell Lines**Human WA09 Embryonic stem cells[@bib55]N/A**Oligonucleotides**Oligo-dT30VN[@bib43]N/AAAGCAGTGGTATCAACGCAGAGTACT30VNTemplate Switching Oligo[@bib43]N/AAAGCAGTGGTATCAACGCAGAGTACATrGrG+GISPCR oligo[@bib43]N/AAAGCAGTGGTATCAACGCAGAGT**Software and Algorithms**R version 3.5.1 (Feather Spray)The R Project<https://www.r-project.org>scran[@bib31]<https://bioconductor.org/packages/release/bioc/html/scran.html>scater[@bib36]<https://bioconductor.org/packages/release/bioc/html/scater.html>Rtsne[@bib59]<https://cran.r-project.org/web/packages/Rtsne/index.html>edgeR[@bib47]<https://bioconductor.org/packages/release/bioc/html/edgeR.html>subread[@bib27]<http://subread.sourceforge.net>Rsubread[@bib28]<https://bioconductor.org/packages/release/bioc/html/Rsubread.html>limma[@bib45]<https://bioconductor.org/packages/release/bioc/html/limma.html>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Wolf Reik (<wolf.reik@babraham.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Human WA09-NK2 ESCs ([@bib55]) were kindly provided by Austin Smith and grown under naive or primed conditions.

Method Details {#sec4.4}
--------------

### Cell culture and collection {#sec4.4.1}

Naive hESCs were grown in 6-well dishes on mouse embryonic fibroblasts in N2B27 supplemented with human LIF, 1μM Chiron, 1μM PD03 and 2μM Gö6983. 1 passage before sorting, cells were plated on 6-well plates coated with Matrigel (growth-factor reduced). Primed hESCs were grown in 6-well dishes coated with Vitronectin in E8 media. For collection, hESCs were dissociated with Accutase and sorted in 96 well plates containing lysis buffer on a BD Aria Cell sorter, gating for cell size and granularity. In each plate, 4 wells were left empty as negative controls. Plates were immediately spun down and frozen at −80°C until subsequent processing. This was performed in two batches -- the first batch contained 96 cells from each condition, while the second batch contained 384 cells from each condition (480 cells in total per condition).

### Library preparation and sequencing {#sec4.4.2}

Single-cells were sorted in 2uL of Lysis Buffer (0.2% v/v Triton X-100 (Sigma-Aldrich, cat. no. T9284) with 2U/ul RNase Inhibitor (Clontech, cat. no. 2313A)) in 96 well plates, spun down and immediately frozen at −80°C. cDNA from sorted single cells was prepared following the SmartSeq2 protocol  ([@bib43]). Briefly, oligo-dT primer, dNTPs (ThermoFisher, cat. no. 10319879) and ERCC RNA Spike-In Mix (1:25,000,000 final dilution, Ambion, cat. no. 4456740) were added to the single-cell lysates, and Reverse Transcription and PCR were performed. The cDNA libraries for sequencing were prepared using Nextera XT DNA Sample Preparation Kit (Illumina, cat. no. FC-131-1096), according to the protocol supplied by Fluidigm (PN 100-5950 B1). Libraries from 96 single cells were pooled and purified using AMPure XP beads (Beckman Coulter). Pooled samples were sequenced on an Illumina HiSeq 2500 instrument, using paired-end 100-bp reads. On average, we obtained 2.1 × 10^6^ reads per cell in batch 1 and 0.5 × 10^6^ reads per cell in batch 2.

### Immunofluorescence Analysis {#sec4.4.3}

Antibody staining was performed as previously described ([@bib48]). Briefly, hESCs were cytospun, after fixation with 2% PFA for 30 minutes at room temperature. Cells were permeabilised with 0.5% Triton X-100 in PBS for 1h; blocked with 1% BSA in 0.05%Tween20 in PBS (BS) for 1h; incubation of the appropriate primary antibody diluted in BS; followed by wash in BS and secondary antibody. Secondary antibody was Alexa Fluor conjugated (Molecular Probes) diluted 1:1000 in BS and incubated for 30 minutes. Incubations were performed at room temperature unless otherwise stated. DNA was counterstained with 5 μg/mL DAPI in PBS. Single optical sections were captured with a Zeiss LSM780 microscope (63x oil-immersion objective). Fluorescence semi-quantification analysis was performed with Volocity 6.3 (Improvision).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Alignment and read counting {#sec4.5.1}

Read pairs were aligned to a reference consisting of the hg38 build of the human genome as well sequences for the ERCC spike-in transcripts. This was performed using the subread aligner v1.6.0 ([@bib27]) in paired-end mode with unique alignment. Each read pair was then assigned to a gene in the Ensembl GRCh38 v91 annotation or to the spike-in transcripts. This was done using the featureCountsfunction in the *Rsubread* package v1.28.1 ([@bib28]). Only reads with mapping quality scores above 10 were used for counting. Read counts from technical (sequencing) replicates of the same cell were added together prior to further analysis. On average, over 71% of reads mapped to the genome with over 59% mapped to exons.

### Quality control on cells and genes {#sec4.5.2}

A range of quality metrics were computed for each cell ([Figure S1](#mmc1){ref-type="supplementary-material"}A) using the calculateQCMetrics function in the *scater* package v1.6.3 ([@bib36]). For each metric, outlier values were identified as those that were more than three median absolute deviations from the median. Low quality cells were identified in each batch, as those with small outlier values for the log-transformed total count; small outliers for the log-transformed number of expressed genes; large outliers for the proportion of read pairs assigned to mitochondrial genes; or large outliers for the proportion of read pairs assigned to spike-in transcripts. These cells were removed from the dataset prior to further analysis, leaving 414 naive and 423 primed cells remained for downstream analysis.

The cell cycle phase for each cell was identified using the cyclone classifier ([@bib49]) implemented in the *scran* package v1.6.9. This was performed with a set of human marker genes, identified by training the classifier on a pre-existing hESC dataset ([@bib25]).

### Normalization of cell-specific biases {#sec4.5.3}

For the endogenous genes, cell-specific size factors were computed using the deconvolution method ([@bib30]) with pre-clustering. For each gene, the count for each cell was divided by the appropriate size factor. A pseudo-count of 1 was added, and the value was log~2~-transformed to obtain log-normalized expression values. This was repeated using the spike-in transcripts, where the size factor for each cell was proportional to the sum of counts for all spike-in transcripts ([@bib32]).

### Feature selection and dimensionality reduction {#sec4.5.4}

Feature selection was performed by computing the variance of the normalized log-expression values across cells for each endogenous gene or spike-in transcript. To represent technical noise, a mean-dependent trend was fitted to the variances of the spike-in transcripts using the trendVar function in the *scran* package ([@bib31]). This was done separately for each batch of cells to ensure that large variances were not driven by uninteresting batch effects. The decomposeVar function was used to obtain the biological component of the variance by subtracting the fitted value of the trend (i.e., the technical component) from the total variance of each gene. The combineVar function was then used to consolidate statistics across batches.

Batch effects were removed from the log-expression matrix using the removeBatchEffects function from the *limma* package v3.34.9 ([@bib45]). This involved performing a linear regression on the log-expression profile of each gene and setting the blocking term for the batch to zero, which was possible for this data due to the balanced naive-primed composition of each batch. Principal component analysis was applied to the corrected expression matrix, only using the genes with positive biological components. This was performed with the denoisePCA function from *scran* to determine the number of principal components to retain. t-SNE was performed on the retained PCs using the *Rtsne* package v0.13.

### Testing for differential expression between conditions {#sec4.5.5}

Counts for the naive and primed cells within each batch were pooled to obtain four sets of pseudo-bulk counts ([@bib29]). Low-abundance genes with average counts below 5 were removed and normalization was performed on the remainders with the trimmed mean of M-values method ([@bib46]). Genes were tested for differential expression (DE) between naive and primed conditions using the quasi-likelihood framework in the *edgeR* package v3.20.9 (Y. [@bib9]). The experimental design was parameterized using an additive design containing a condition term and the batch blocking factor. DE genes were defined as those with significant differences between conditions at a FDR of 5%.

To validate the identified marker genes, DE genes in three different bulk RNA-seq datasets ([@bib41], [@bib58], [@bib17]) were identified using the quasi-likelihood framework. This used the procedure described above with the only difference being that DE genes were defined as having absolute log-fold changes significantly greater than 0.5 at a FDR of 5% ([@bib35]). This ensured that the DE analysis focused on genes with strong differences in expression. The results of the analysis for each dataset were visualized using volcano plots. For comparison, we highlighted the top 200 naive markers and the top 200 primed markers from our single-cell data (ranked by p value) on each plot.

### Detecting the intermediate population {#sec4.5.6}

Dimensionality reduction was performed as previously described using only the cells in the naive condition. The retained principal components were used for hierarchical clustering of the cells with the hclust function in *R*, using Ward linkage on the Euclidean distances. Clusters of cells were identified using a simple tree cut, where the optimal number of clusters was determined by maximizing the average silhouette width. The cluster of cells located between the bulk of cells from the naive and primed conditions in the PCA plot was denoted as the intermediate population.

The intermediate population was characterized by testing for differential expression relative to the other naive cells or to the primed cells. This was done using t tests on the log-expression values ([@bib53]) after blocking on the batch. For each contrast, several candidates were chosen from the top set of DE genes for further validation by immunofluorescence staining.

### Exploring lineage-related heterogeneity {#sec4.5.7}

Dimensionality reduction was performed for each condition as previously described. For the naive condition, cells in the intermediate population were removed. PCA plots were colored according to the expression of *CDK1* to represent cell cycle activity ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Dimensionality reduction in each condition was also repeated using only genes that were specific for the germ layers ([Table S3](#mmc4){ref-type="supplementary-material"}) to detect potential early lineage commitment. Again, cells in the intermediate population were excluded. The resulting t-SNE plots were colored by expression of the mesoderm marker *SNAI1* ([@bib14]), the ectoderm marker *ITGA6* ([@bib66]) or the endoderm marker *PAF1* ([@bib67]) to visualize any lineage-related substructure and by the expression of cell-cycle marker *CDK1* ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

### Correlations with epigenetic modulators {#sec4.5.8}

Pairwise correlations of selected lineage and pluripotency markers to epigenetic modulators ([Table S4](#mmc5){ref-type="supplementary-material"}) were calculated using the correlatePairs function from the *scran* package. This involved computing Spearman's rank correlation coefficients between the log-expression profiles of lineage marker genes (endoderm, ectoderm, mesoderm, trophectoderm, core pluripotency, naive pluripotency, formative pluripotency, primed pluripotency and germline) and genes comprising the epigenetic machinery. *P*-values for all pairs were combined and corrected for multiple testing.

To visualize the correlations, we computed the average absolute correlation across naive and primed conditions for each gene pair. We then selected the top 25 lineage/pluripotency markers and the top 25 epigenetic modifiers with the largest average absolute correlations. For each condition, a heatmap of the correlation values between all pairs of the selected genes was constructed using the pheatmap function from the *pheatmap* package v1.0.8.

### Mapping temporal trajectories in early embryos {#sec4.5.9}

Naive marker genes were defined from our data as those that were DE relative to primed cells (using the pseudo-bulk statistics, above) at a FDR of 5% and with a log~2~-fold change of 10; were present in at least 25% of naive cells; and were present in no more than 5% of primed cells. Similarly, primed marker genes were defined as those that were DE relative to naive cells at a FDR of 5% and with a log~2~-fold change of −10; were present in at least 25% of primed cells; and were present in no more than 5% of naive cells.

A marker gene was considered to be expressed in a cell from a different dataset if its (normalized) count was greater than 10. For each cell, we calculated the proportion of naive markers that were expressed. This was repeated for the primed markers. Cells were mapped onto the "naïve-primed axis" based on these proportions. Large naive proportions and small primed proportions indicate that the cell is naive, and vice versa for primed cells.

Mapping onto the naive-primed axis was performed for cells collected from human pre-implantation embryos ([@bib42]), mouse embryos ([@bib37]), and cynomolgus monkey embryos ([@bib39]). Mouse homologs for the marker genes were identified using the getLDS function from the *biomaRt* package ([@bib13]), using the homology relationships predicted by Ensembl. Monkey homologs for marker genes were identified as those with the same gene symbol. As a control, we also performed remapping using the naive, primed and intermediate population cells in our own dataset.

To assess the expression of intermediate population genes in the human pre-implantation embryos ([@bib42]), an intermediate-naive axis was constructed similarly to the naive-primed axis. Intermediate population marker genes were considered uniquely expressed in the subpopulation by a log~2~-fold change of 5 against both the naive and the primed population at a FDR of 5%, and by their presence in less than 25% of the naive and the primed cells.

Data and Software Availability {#sec4.6}
------------------------------

### Code availability {#sec4.6.1}

All analysis code is available at <https://github.com/MarioniLab/NaiveHESC2016>.

### Deposition of sequencing data {#sec4.6.2}

The accession number for the scRNA-seq data reported in this paper is ArrayExpress: [E-MTAB-6819](array-express:E-MTAB-6819){#intref0060}.
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